News & Blog

Tag Archives: GBM

Recently in Brain Tumor Research: Reporting back from the 2014 American Society of Clinical Oncology Annual Meeting

With more than 30,000 attendees from across the oncology field, the American Society of Clinical Oncology’s (ASCO) Annual Meeting is one of the largest and most important yearly gatherings in the field of cancer research.  This year’s 50th ASCO annual meeting (May 30 – June 3) was one of the biggest to-date, with the society [...]

Can Army Cadets from West Point Help Pediatric Brain Tumor Treatments Get to Market?

During a mid-March scientific and policy meeting, a group of cadets from the United States Military Academy at West Point – none biology or pre-med majors – stood before a group of leading international pediatric cancer researchers, representatives from major biopharmaceutical companies, and officials from government agencies like the National Cancer Institute, U.S. Food and [...]

Confronting Acquired Resistance in Brain Tumors

“Despite their ability to induce dramatic tumor responses with fewer side effects, the effectiveness of targeted therapies is currently limited because the majority of patients using these agents develop resistance over time, resulting in a relapse or worsening of the cancer” – A post on the website of Massachusetts General Hospital in Fall, 2011 The [...]

Share